This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Inhibrx Biosciences, Inc., Phylaxis Bioscience, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 11 
1 out of 1 Years Active: 2025
Title: The Innovations of Tony Dung-Ling Yao
Introduction
Tony Dung-Ling Yao is an accomplished inventor based in Denver, Colorado. He has made significant contributions to the field of biotechnology, particularly in the development of IgE-binding proteins. His work has the potential to impact various medical applications, especially in allergy treatments.
Latest Patents
Tony holds a patent for "IgE binding proteins and uses thereof." This patent includes IgE-binding VHH domains, polypeptides, and proteins, along with methods for using these IgE-binding polypeptides and proteins to modulate the biological activity of IgE. This innovation showcases his expertise in creating solutions for complex biological challenges.
Career Highlights
Throughout his career, Tony has worked with notable companies such as Phylaxis Bioscience, LLC and Inhibrx Biosciences, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the biotechnology sector.
Collaborations
Tony has collaborated with talented individuals in his field, including Bryan Becklund and Kyle S. Jones. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tony Dung-Ling Yao is a prominent figure in the field of biotechnology, with a focus on IgE-binding proteins. His patent and career achievements reflect his dedication to advancing medical science. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile